This week, we will discuss the HIT trial- a large randomized study challenging one of the most reflexive responses in hospital medicine: see hyponatremia, fix the sodium. But what if correcting the number doesn’t change what actually matters?
Hiponatremia: El Resumen Visual
La hiponatremia es uno de los trastornos electrolíticos más frecuentes en pacientes hospitalizados y se asocia de manera consistente con peores desenlaces. Su corrección mejora los valores, pero ¿realmente mejora los desenlaces clínicos ?
Revisa el resumen visual por Brian Rifkin y el nuevo formato de #NephJC
Hyponatremia Correction: The Visual Abstract
Hyponatremia is one of the most common electrolyte disorders in hospitalized patients and is consistently linked to worse outcomes. Correcting sodium improves the numbers—but does it improve short-term clinical outcomes?
Check out Brian Rifkin VA and the new #NephJC format
Top Stories in Nephrology 2025
NephJC Shorts: Hypertension and The Extreme Elderly
ASIs Advance: NephJC Shorts on BaxHTN
NephJC Shorts: MCD and FSGS Outcomes
Do nudges increase the use of GDMT in diabetic CKD?
Is tacrolimus superior to MMF in pediatric steroid sensitive nephrotic syndrome?
NephJC Internship Reforms and then Reforms
Underestimating primary aldosteronism?
Should we screen all individuals with hypertension for primary aldosteronism?
Metformin in advanced CKD
Metformin in stage 4 CKD? Catch-up here
Metformin- Should I Stay or Should I Go
KDIGO 2025 ADPKD Guidelines Review
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, and patients. The guidelines incorporate ADPKD-specific care as well as many general CKD management practice points.
La Aldosterona en la sombra
El hiperaldosteronismo primario (HAP) no es solo una entidad de hipertensión resistente; este estudio revela un continuo fisiopatológico que inicia en personas normotensas.
A través de pruebas dinámicas, ¿podría el HAP ser la base oculta de una proporción significativa de la hipertensión? ¿Cómo cambia nuestro enfoque en el diagnóstico y tratamiento?
👀 Veamos el resumen visual creado por Brian Rifkin 🎨✨ y 💬 únete a la conversación en #NephJC por Bluesky.
Undercover Aldosterone
Undercover Aldosterone
HOPE-ing and Coping with Pain in Dialysis
Top Stories in Nephrology 2024
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every big nephrology congress. Probably 1st place won’t surprise anyone; it was the anticipated FLOW of the year, but this Top 10 Nephrology Stories definitely includes some unexpected titles
Estudio RADAR - El Resumen Visual
El Resumen Visual
¿Realmente existen diferencias entre los pacientes con enfermedades renales raras de otras causas de ERC?
Veamos este resumen visual creado por el miembro de la facultad NephEdC, Brian Rifkin, el cual activa el RaDaR hacia las enfermedades renales raras.
